Together, these data suggest that miR-1224 inhibited the metastasis of intestinal-type GC by suppressing the FAK-mediated activation of the STAT3 and NF-κB pathways, and subsequent EMT (Figure 7). Here, NFKB1 is linked to gastric cancer.